View Older Stories View More Recent Stories

Sep 24, 2024 07:30AM Ocugen to Participate in a Fireside Chat at Chardan’s 8th Annual Genetic Medicines Conference
Sep 24, 2024 07:00AM Fractyl Health to Present at Chardan’s 8th Annual Genetic Medicines Conference
Sep 24, 2024 06:00AM Coave Therapeutics to Present Novel Data Highlighting the Potential of its ALIGATER™ Platform to Enhance the Targeted Delivery of Genetic Medicines at Upcoming Conferences
Sep 23, 2024 04:05PM REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines Conference
Sep 23, 2024 08:56AM Dyne Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines Conference
Sep 23, 2024 08:00AM Solid Biosciences to Participate at Chardan’s 8th Annual Genetic Medicines Conference
Sep 23, 2024 08:00AM Spur Therapeutics to Participate in Chardan’s 8th Annual Genetic Medicines Conference
Sep 23, 2024 07:45AM Affinia Therapeutics to Participate in Upcoming Investor and Industry Conferences
Sep 23, 2024 07:00AM Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines Conference
Sep 19, 2024 07:15PM Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference
Sep 19, 2024 07:15PM Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference
Sep 19, 2024 08:06AM Chardan Capital Markets Reiterates Buy Rating on 4D Molecular Therapeutics (FDMT)
Sep 18, 2024 05:17AM Chardan Capital Markets Starts CervoMed (CRVO) at Buy
Sep 16, 2024 05:30AM Atamyo Therapeutics to Provide Corporate Overviews and Updates on Its Pipeline Progress at 6 Upcoming Conferences in the US and Europe
Sep 13, 2024 09:05AM Outlook Therapeutics® Participates in the 2nd Annual Chardan Virtual Ophthalmology Conference Series
Sep 10, 2024 08:00AM Korro to Participate in Upcoming Investor Conferences
Sep 5, 2024 07:30AM Lexeo Therapeutics to Participate in Upcoming Investor Conferences
Sep 4, 2024 04:05PM Adverum Biotechnologies to Participate in Upcoming Fall Investor Conferences
Sep 4, 2024 07:45AM Capsida Biotherapeutics to Participate in Upcoming Investor and Industry Conferences Highlighting Progress With its Wholly Owned Programs in IND-enabling Studies
Sep 3, 2024 08:30AM Tenaya Therapeutics to Participate in Upcoming Investment Conferences
Sep 3, 2024 08:15AM Genprex to Present and Participate at Upcoming September Investor and Industry Conferences
Sep 3, 2024 08:15AM Senti Bio to Participate in Upcoming Investor Conferences
Sep 3, 2024 07:30AM Cognition Therapeutics to Participate in Upcoming September 2024 Investor Conferences
Aug 29, 2024 08:21AM VivoPower's (VVPR) Tembo E-LV Executes a Definitive Merger Agreement with Cactus Acquisition Corp. 1 (CCTS)
Aug 29, 2024 08:20AM Tembo E-LV, a subsidiary of Nasdaq-listed VivoPower International PLC (“VVPR”) executes a definitive Business Combination Agreement with CCTS for a combined enterprise value of US$904 million
Aug 29, 2024 08:00AM Flamingo Therapeutics Announces Participation in Upcoming Investor Conferences
Aug 28, 2024 09:00AM Editas Medicine to Participate in Upcoming Investor Conferences
Aug 28, 2024 08:00AM Vor Bio to Participate in Upcoming Investor Conferences
Aug 28, 2024 08:00AM Prime Medicine to Participate in Upcoming Investor Conferences
Aug 27, 2024 08:00AM Silence Therapeutics to Webcast Presentations at Upcoming September Investor Conferences
Aug 22, 2024 07:52AM Allurion Technologies (ALUR) PT Lowered to $2.50 at Chardan Capital Markets
Aug 21, 2024 05:36AM Chardan Capital Markets Starts Clearside Biomedical (CLSD) at Buy
Aug 19, 2024 09:00AM Avidity Biosciences Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Aug 15, 2024 06:17AM Avidity Biosciences Inc. (RNA) Prices Upsized 7.32M Share Offering at $41/sh
Aug 14, 2024 08:30PM Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock
Aug 14, 2024 08:35AM Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
Aug 14, 2024 05:50AM Chardan Capital Markets Assumes Zura Bio Ltd. (ZURA) at Buy
Jul 31, 2024 04:01PM Adagio Medical Announces the Closing of the Business Combination with ARYA IV, Creating a Publicly Traded Company Focused on the Innovative Technologies for Treatment of Cardiac Arrhythmias
Jul 31, 2024 05:44AM Chardan Capital Markets Assumes MeiraGTx Holdings plc (MGTX) at Buy
Jul 30, 2024 07:55AM Pershing Square USA, Ltd. Announces Proposed IPO Size
Jul 17, 2024 01:07PM Chardan Capital Markets Reiterates Buy Rating on 4D Molecular Therapeutics (FDMT)
Jul 16, 2024 10:00AM Gateway Group Announces Preliminary Sponsors and Additional Presenting Companies for September Gateway Conference
Jul 9, 2024 12:13PM Vyome to go public and trade on the Nasdaq Capital Market under the ticker symbol “HIND”
Jul 9, 2024 08:31AM ReShape Lifesciences Inc. (RSLS) to Merge with Vyome Therapeutics, Enters Asset Purchase Agreement With Biorad Medisys
Jul 9, 2024 08:31AM ReShape Lifesciences® Enters Into Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
Jul 9, 2024 06:28AM Pershing Square USA, Ltd. Announces Launch of IPO Roadshow
Jul 8, 2024 06:32AM Chardan Capital Markets Starts Cargo Therapeutics (CRGX) at Buy
Jun 28, 2024 08:00AM Eyenovia Inc (EYEN) Prices 7.56M Share Offering at $0.66/sh
Jun 28, 2024 08:00AM Eyenovia Announces Pricing of $5M Registered Direct Offering
Jun 27, 2024 05:36PM Form SC 13G ANEW Medical, Inc. Filed by: CHARDAN CAPITAL MARKETS LLC
View More Recent Stories View Older Stories